Do statins change your cancer risk?

Statins attract claims that point in opposite directions. One camp says they quietly raise cancer risk. Another sells them as an accidental way to prevent cancer. Both stories spread widely. Both cannot be right.

NCI's patient summary on colorectal cancer prevention takes the question head on. Studies have shown that taking statins does not raise or lower the risk of colorectal cancer.

NCI states this plainly.

People often treat a neutral result like a shrug. They assume the scientists just did not look hard enough.

That is backwards. To say something neither raises nor lowers risk, researchers have to study a great many people. Then they have to find that both groups came out the same. A finding of no difference is still a finding.

A widely used drug studied for cancer risk, landing on neutral, is reassurance. It is not a gap.

It also means you can decide about statins on the grounds they were always meant for. Your cholesterol. Your heart risk. How well you tolerate the medicine.

The same NCI summary is not neutral about everything. That makes the statin conclusion easier to trust.

Take aspirin. NCI reports that daily aspirin for at least two years lowers the risk of colorectal cancer. It also lowers the risk of death from colorectal cancer. NCI pairs that with harm right away. Daily use brings a higher risk of stroke. It also brings a higher risk of bleeding in the stomach and intestines.

Other anti-inflammatory drugs are less settled. NCI says it is not known whether NSAIDs other than aspirin lower colorectal cancer risk. NSAIDs are common pain and swelling medicines. Celecoxib did cut the return of adenomas in studies. Adenomas are growths in the bowel that can turn into cancer. But NCI notes it is not clear whether that means a lower risk of colorectal cancer. Possible harms on the list include kidney problems, bleeding and heart issues.

A few practical points follow.

If someone told you statins cause colorectal cancer, NCI's summary says otherwise. Talk with your clinician before changing any medicine.

Maybe you are thinking about aspirin because you read it prevents bowel cancer. That is a real conversation to have with a clinician. It is not a choice to make in a pharmacy aisle. The bleeding and stroke risks are why it needs someone who knows your history.

And if a seller pitches a supplement because a prescription drug "works this way", slow down. Check whether the study they point at exists. Check what it actually measured.

NCI's summary says finding and treating colorectal cancer early may prevent death from it. Screening is covered on its own page, linked below. Checking whether yours is up to date is a sensible step.

Claims about ordinary medicines and cancer spread constantly, in both directions. A few habits sort most of them fast.

See whether the claim names a specific cancer. Findings are usually specific. The conclusion here is about colorectal cancer. A claim that stretches one result across every cancer has already outrun its evidence.

See whether the source reviews the whole body of research. One study on its own is weak. Individual studies disagree all the time. That is normal, and it is why summaries exist.

See whether harms appear next to benefits. A source that only lists upside is selling something. Notice that the same federal summary that praises aspirin names stroke and gut bleeding in the same breath.

Last, see what you are being asked to do. A claim that ends with "so stop your prescription" or "so buy this instead" deserves far more doubt than one that ends with "so ask your clinician".